Non lethal Inhibition of Gut Microbial Trimethylamine Production for the Treatment of Atherosclerosis: Cell Linking anaerobic gut bacteria and cardiovascular disease Nature Microbiology Full article: Gut microbes with the gbu genes determine TMAO production from L carnitine intake and serve as a biomarker for precision nutrition Frontiers The gut microbial metabolite trimethylamine N oxide and cardiovascular diseases Identification of TMAO producer phenotype and hostdietgut dysbiosis by carnitine challenge test in human and germ free mice Gut Dietary bioactive ingredients to modulate the gut microbiota derived metabolite TMAO. New opportunities for functional food development Food & Function (RSC Publishing) DOI:10.1039 D0FO01237H